FriskaAi and Dexcom Collaborate on CGM Data Integration for Enhanced Diabetes Management

FriskaAi has partnered with DexCom to integrate data from DexCom's G7 and G6 Continuous Glucose Monitoring (CGM) Systems into their AI-powered healthcare platform. The integration aims to support physicians and patients with actionable personalized care management programs for diabetes and other chronic diseases. The partnership will enable patients to take control of their health journey in partnership with their clinical team using advanced AI-powered algorithms and real-time glucose level monitoring.

FriskaAi has announced a significant partnership with DexCom, Inc., the global leader in glucose biosensing, to integrate data from DexCom's G7 and G6 Continuous Glucose Monitoring (CGM) Systems into their AI-powered healthcare platform. This collaboration aims to support physicians and patients with actionable personalized care management programs for diabetes and other chronic diseases.

Under the agreement, data from DexCom CGMs will be integrated with FriskaAi, enabling real-time glucose level monitoring and personalized health insights. The FriskaAi platform, which is EHR-agnostic and leverages advanced AI and mobile technology, will generate personalized health recommendations for patients and provide clinicians with actionable reports to inform care decisions [1].

The integration of DexCom CGMs with FriskaAi will allow patients to continuously monitor their glucose levels without the need for fingerpricks. The CGMs offer customizable alerts for high or low glucose levels, as well as predictive alerts to help users spend more time in range [2]. The FriskaAi mobile app will securely integrate with DexCom CGMs and other smart devices, providing a comprehensive platform for health management.

The partnership is particularly significant given the growing prevalence of diabetes in the United States. According to the Centers for Disease Control and Prevention, more than 38 million Americans are living with diabetes, making it a major public health concern [3]. Effective management of diabetes has become a foundational element of preventive medicine, and the integration of DexCom CGMs with FriskaAi aims to support this goal.

Shaji Nair, CEO of FriskaAi, commented on the partnership: "Dexcom's pioneering CGMs are vital tools not only for diabetes management but also for informing broader care decisions. FriskaAi is excited about the potential this integration with Dexcom presents to the physicians relying on our platform for chronic disease management and the patients seeking greater control over their health and wellness" [1].

The FriskaAi platform will continuously monitor aggregated health data to help physicians identify trends and risks within their patient populations, enabling more proactive and preventive care strategies [1]. This integration represents a significant step forward in the use of AI and mobile technology to improve patient outcomes and support preventive care.

References:

[1] https://www.miamiherald.com/press-releases/article311688273.html
[2] https://www.joplinglobe.com/region/friskaai-and-dexcom-enter-cgm-data-integration-agreement/article_7d914367-f45e-58e0-b5bb-88db809e1bbf.html
[3] Centers for Disease Control and Prevention. (2021). National Diabetes Statistics Report, 2020. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.